Intermittent Fasting
14 articles on Intermittent Fasting, researched and written by the Shotlee Editorial Team from primary sources.
The Most Confronting Side Effect of Wegovy Weight Loss Wasn't Physical
While physical side effects of Wegovy are well-documented, one patient's experience highlights a profound, non-physical challenge: the shift in how society perceives and treats individuals after significant weight loss.
7 min read
Peptides, GLP-1s, and MAHA: A New Era in Wellness
The world of wellness is rapidly evolving, with groundbreaking advancements in peptide therapy and GLP-1 medications offering new avenues for health management and weight loss. This article delves into the science behind these innovations, explores the potential of 'MAHA' (Maximum Healthspan Aging), and discusses how individuals can navigate this exciting new frontier.
9 min read
Ozempic, Wegovy & Mounjaro: How GLP-1s Are Reshaping the Diet Industry
The landscape of weight loss and diet trends is undergoing a seismic shift, largely driven by the widespread adoption of GLP-1 receptor agonists. From Ozempic to Wegovy and Mounjaro, these medications are not just changing how individuals manage their weight but are fundamentally altering the food industry and the very concept of dieting.
7 min read
Ricki Lake's 40lb Weight Loss: A Diet, Fitness, and Self-Tracking Success Story
Ricki Lake shares her successful 40-pound weight loss journey, achieved through a dedicated approach to diet, consistent exercise, and insightful self-monitoring, offering valuable lessons for those seeking sustainable health improvements.
6 min read
Peptide Therapy & The Biohacking Boom: Navigating Unregulated Wellness
The world of biohacking is increasingly embracing peptides, but what's the reality behind the hype? This article delves into the science, the risks of unregulated substances, and the potential impact of regulatory changes on access to these compounds.
10 min read
Gut Reset Era 2026: Redefining Weight Loss and Digestive Health
In 2026, the gut reset era is transforming weight loss by linking it inseparably to digestive health and metabolism. No longer isolated goals, bloating, slow metabolism, and weight gain are addressed holistically for lasting results. From microbiome breakthroughs to personalized tech tools, this integrated approach promises better outcomes.
7 min read
Elon Musk Before and After: Tesla CEO's Look After Mounjaro
Elon Musk's dramatic before and after photos have gone viral, spotlighting his slimmer appearance after confirming Mounjaro use. The Tesla CEO's 'Ozempic Santa' post ignited speculation on GLP-1 drugs' role in his 30-pound weight loss. Understand the science behind 'Mounjaro face' and real transformations.
6 min read
Farmer Blames Ozempic, Mounjaro for 'Potato Mountain' Surplus
A veteran potato farmer in Lincolnshire is staring down a 'potato mountain' of 600 tons he can't sell, blaming weight-loss drugs like Ozempic and Mounjaro. With key buyer McCain not ordering, Andy Goodacre links the surplus to slimmer appetites from GLP-1 meds. Fish friers confirm the trend is hitting chip shops too.
5 min read
GLP-1 Drugs Boost Dairy Demand for Yogurt and Cottage Cheese
GLP-1 drugs like Ozempic and Wegovy are reshaping eating habits, slashing demand for pastries while surging sales of protein-rich yogurt and cottage cheese. Studies show users cut grocery spending by 6-9%, favoring nutrient-dense dairy. Dairy giants like Arla and Ehrmann are capitalizing with GLP-1-friendly products.
10 min read
Donna Kelce Denies Weight-Loss Drugs, Credits Intermittent Fasting
Donna Kelce, mother of NFL stars Travis and Jason, is clapping back at online speculation that her slimmer figure on The Traitors came from weight-loss drugs like Ozempic. The 73-year-old reveals she lost about 30 pounds over a year through intermittent fasting alone. Her story highlights natural paths to metabolic health amid GLP-1 hype.
5 min read
Intermittent Fasting No Better for Weight Loss Than Dieting, Cochrane Review ...
New Cochrane research reveals intermittent fasting offers no weight loss advantage over traditional dietary advice or even no intervention at all. Analyzing 22 studies with 1,995 overweight or obese adults, the review highlights similar outcomes across groups. Discover the details and potential benefits beyond the scale.
5 min read
How Restaurants Are Adapting to Rising GLP-1 Usage Like Ozempic
Popular GLP-1 drugs like Ozempic and Wegovy are curbing appetites, prompting restaurants to adapt with specialized menus. Cuba Libre's Barry Gutin explains their high-protein, smaller-portion offerings designed with a doctor's input. This trend signals a lasting change in dining habits.
5 min read
Brain Insulin Resistance: Driving Alzheimer's as Type 3 Diabetes
Alzheimer's disease may be more than just amyloid plaques—emerging evidence points to brain insulin resistance as a core driver, earning it the label 'Type 3 diabetes.' A recent Polish study uncovers how impaired insulin signaling starves neurons of energy and accelerates toxic protein buildup. Discover the science and potential therapies like GLP-1 agonists that could change the game.
5 min read
Mounjaro Users: Doctor's Key Advice for Brussels Sprouts on Christmas
A survey indicates many worry about weight gain during Christmas. For Mounjaro users, managing holiday meals can be especially challenging. A doctor provides advice on enjoying Christmas dinner without compromising progress, including intermittent fasting and mindful eating strategies.
4 min read